| Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
|---|---|---|---|---|---|---|---|
| ENST00000480205 | PSMD6-208 | 657 | - | ENSP00000418843 | 138 (aa) | - | H7C531 |
| ENST00000475036 | PSMD6-205 | 1045 | - | - | - (aa) | - | - |
| ENST00000394431 | PSMD6-202 | 1349 | XM_024453841 | ENSP00000377952 | 351 (aa) | XP_024309609 | Q15008 |
| ENST00000478185 | PSMD6-207 | 469 | - | ENSP00000418303 | 144 (aa) | - | C9J7B7 |
| ENST00000476464 | PSMD6-206 | 2052 | - | - | - (aa) | - | - |
| ENST00000463139 | PSMD6-203 | 2621 | - | - | - (aa) | - | - |
| ENST00000492933 | PSMD6-210 | 1495 | XM_011534288 | ENSP00000418695 | 442 (aa) | XP_011532590 | Q15008 |
| ENST00000295901 | PSMD6-201 | 1430 | XM_005265619 | ENSP00000295901 | 389 (aa) | XP_005265676 | Q15008 |
| ENST00000497315 | PSMD6-211 | 701 | - | - | - (aa) | - | - |
| ENST00000497323 | PSMD6-212 | 717 | - | ENSP00000418887 | 226 (aa) | - | C9J0E9 |
| ENST00000467853 | PSMD6-204 | 4583 | - | - | - (aa) | - | - |
| ENST00000482510 | PSMD6-209 | 1176 | - | ENSP00000419227 | 350 (aa) | - | Q15008 |
| ensgID | Trait | pValue | Pubmed ID |
|---|---|---|---|
| ENSG00000163636 | Stroke | 4.9108607E-004 | 19369658 |
| ENSG00000163636 | Platelet Function Tests | 1.8523800E-005 | - |
| ENSG00000163636 | Child Development Disorders, Pervasive | 5.8000000E-005 | - |
| ENSG00000163636 | Diabetes Mellitus, Type 2 | 8E-11 | 22158537 |
| ENSG00000163636 | 13,16,19-docosatrienoic acid | 8E-6 | 23934736 |
| ENSG00000163636 | Diabetes Mellitus, Type 2 | 1E-7 | 26818947 |

| Ensembl ID | Gene Symbol | Coverage | Identiy | Ortholog | Gene Symbol | Coverage | Identiy | Species |
|---|---|---|---|---|---|---|---|---|
| ENSG00000163636 | PSMD6 | 99 | 49.858 | WBGene00004463 | rpn-7 | 96 | 47.342 | Caenorhabditis_elegans |
| ENSG00000163636 | PSMD6 | 99 | 71.552 | FBgn0028688 | Rpn7 | 100 | 70.180 | Drosophila_melanogaster |
| ENSG00000163636 | PSMD6 | 99 | 38.298 | YPR108W | 94 | 37.101 | Saccharomyces_cerevisiae |
| Go ID | Go_term | PubmedID | Evidence | Category |
|---|---|---|---|---|
| GO:0000165 | MAPK cascade | - | TAS | Process |
| GO:0000209 | protein polyubiquitination | - | TAS | Process |
| GO:0000502 | proteasome complex | 17323924. | IDA | Component |
| GO:0002223 | stimulatory C-type lectin receptor signaling pathway | - | TAS | Process |
| GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | - | TAS | Process |
| GO:0005515 | protein binding | 25416956. | IPI | Function |
| GO:0005576 | extracellular region | - | TAS | Component |
| GO:0005654 | nucleoplasm | - | TAS | Component |
| GO:0005829 | cytosol | - | TAS | Component |
| GO:0005838 | proteasome regulatory particle | 21873635. | IBA | Component |
| GO:0006508 | proteolysis | 10723133. | NAS | Process |
| GO:0006521 | regulation of cellular amino acid metabolic process | - | TAS | Process |
| GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | - | TAS | Process |
| GO:0016579 | protein deubiquitination | - | TAS | Process |
| GO:0016887 | ATPase activity | 10723133. | NAS | Function |
| GO:0022624 | proteasome accessory complex | - | ISS | Component |
| GO:0030234 | enzyme regulator activity | - | IEA | Function |
| GO:0031145 | anaphase-promoting complex-dependent catabolic process | - | TAS | Process |
| GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | - | TAS | Process |
| GO:0033209 | tumor necrosis factor-mediated signaling pathway | - | TAS | Process |
| GO:0034774 | secretory granule lumen | - | TAS | Component |
| GO:0038061 | NIK/NF-kappaB signaling | - | TAS | Process |
| GO:0038095 | Fc-epsilon receptor signaling pathway | - | TAS | Process |
| GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 21873635. | IBA | Process |
| GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | - | TAS | Process |
| GO:0043312 | neutrophil degranulation | - | TAS | Process |
| GO:0043488 | regulation of mRNA stability | - | TAS | Process |
| GO:0043687 | post-translational protein modification | - | TAS | Process |
| GO:0050790 | regulation of catalytic activity | - | IEA | Process |
| GO:0050852 | T cell receptor signaling pathway | - | TAS | Process |
| GO:0055085 | transmembrane transport | - | TAS | Process |
| GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | - | TAS | Process |
| GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | - | TAS | Process |
| GO:0070498 | interleukin-1-mediated signaling pathway | - | TAS | Process |
| GO:0090090 | negative regulation of canonical Wnt signaling pathway | - | TAS | Process |
| GO:0090263 | positive regulation of canonical Wnt signaling pathway | - | TAS | Process |
| GO:1901990 | regulation of mitotic cell cycle phase transition | - | TAS | Process |
| GO:1902036 | regulation of hematopoietic stem cell differentiation | - | TAS | Process |
| GO:1904813 | ficolin-1-rich granule lumen | - | TAS | Component |